# Cosmo Pharmaceuticals N.V. (CMOPF)

> Healthcare · IE · Reports in EUR

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CMOPF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | € 49.87M | € -4.72M | € -9.50M | € 4.30M | € 563.85M |
| 2025 | € 105.95M | € -3.67M | € -16.24M | € 4.26M | € 481.78M |
| 2024 | € 276.40M | € 138.04M | € 162.40M | € 2.20M | € 498.33M |
| 2023 | € 98.46M | € -5.23M | € 32.13M | € 1.84M | € 422.16M |
| 2022 | € 111.48M | € 18.81M | € 31.35M | € 173.60M | € 456.93M |
| 2021 | € 77.60M | € 25.84M | € 8.50M | € 169.92M | € 505.28M |
| 2020 | € 76.29M | € -9.89M | € 11.10M | € 168.14M | € 400.13M |
| 2019 | € 78.01M | € -30.48M | € -26.33M | € 164.84M | € 393.73M |
| 2018 | € 83.00M | € -22.78M | € -15.26M | € 158.15M | € 443.76M |
| 2017 | € 86.95M | € -41.67M | € -27.89M | € 4.48M | € 470.12M |
| 2016 | € 89.01M | € 25.17M | € 25.85M | € 5.31M | € 415.55M |
| 2015 | € 79.77M | € 326.53M | € -54.16M | € 8.13M | € 403.64M |
| 2014 | € 105.04M | € 96.70M | € 84.73M | € 10.93M | € 152.28M |
| 2013 | € 75.57M | € 90.50M | € 8.11M | € 11.75M | € 220.14M |
| 2012 | € 64.53M | € 13.65M | € 15.33M | € 12.84M | € 124.39M |
| 2011 | € 45.48M | € 10.32M | € 10.75M | € 2.18M | € 63.19M |
| 2010 | € 34.04M | € 5.17M | € 510.5K | € 3.50M | € 58.07M |
| 2009 | € 38.04M | € 5.77M | € -4.05M | € 2.98M | € 59.80M |
| 2008 | € 49.17M | € 13.53M | € -25.76M | € 4.29M | € 43.24M |
| 2007 | € 32.03M | € 169.7K | € -5.24M | € 1.54M | € 35.15M |
| 2006 | € 22.86M | € -206.6K | € -3.05M | € 8.70M | € 5.34M |
| 2005 | € 23.83M | € 1.29M | € -3.84M | € 21.56M | € 631.0K |
| 2004 | € 14.44M | € -1.37M | € -2.64M | € 19.34M | € -880.0K |
| 2003 | € 4.34M | € -863.5K | € -857.2K | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.21 |
| Current Ratio | 10.66 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.52 |
| Gross Debt / FCF | 0.27 |

## Other views

- [Metrics](https://sponda.capital/en/CMOPF.md)
- [Charts](https://sponda.capital/en/CMOPF/charts.md)
- [Compare](https://sponda.capital/en/CMOPF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.